Patents by Inventor Jason J. Hamann

Jason J. Hamann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931580
    Abstract: An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: March 19, 2024
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David J. Ternes, Jason J. Hamann, Stephen B. Ruble, Juan Gabriel Hincapie Ordonez, Manfred Franke
  • Publication number: 20230149716
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 18, 2023
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble
  • Patent number: 11577083
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: February 14, 2023
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble
  • Patent number: 11446501
    Abstract: According to various method embodiments, a person is indicated for a therapy to treat a cardiovascular disease, and the therapy is delivered to the person to treat the cardiovascular disease. Delivering the therapy includes delivering a vagal stimulation therapy (VST) to a vagus nerve of the person at a therapeutically-effective intensity for the cardiovascular disease that is below an upper boundary at which upper boundary the VST would lower an intrinsic heart rate during the VST.
    Type: Grant
    Filed: June 2, 2020
    Date of Patent: September 20, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Weiying Zhao, Quan Ni, Stephen B. Ruble, Jason J. Hamann
  • Publication number: 20210154478
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble
  • Patent number: 10940316
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: March 9, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble
  • Patent number: 10835306
    Abstract: A medical device including an elongate member having a proximal end configured to be electrically coupled to an energy source, and a distal member disposed at a distal end of the elongate member. The distal member may include a plurality of contact elements configured to deliver stimulating energy to innervated tissue, detect a response from the innervated tissue to the stimulating energy, and deliver therapeutic energy to the innervated tissue based on the response from the innervated tissue.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: November 17, 2020
    Assignee: Boston Scientifique Scimed, Inc.
    Inventors: Manfred Franke, Bryan Allen Clark, Aiden Flanagan, Juan Hincapie Ordonez, Jason J. Hamann, Allan Shuros
  • Publication number: 20200289823
    Abstract: According to various method embodiments, a person is indicated for a therapy to treat a cardiovascular disease, and the therapy is delivered to the person to treat the cardiovascular disease. Delivering the therapy includes delivering a vagal stimulation therapy (VST) to a vagus nerve of the person at a therapeutically-effective intensity for the cardiovascular disease that is below an upper boundary at which upper boundary the VST would lower an intrinsic heart rate during the VST.
    Type: Application
    Filed: June 2, 2020
    Publication date: September 17, 2020
    Inventors: Weiying Zhao, Quan Ni, Stephen B. Ruble, Jason J. Hamann
  • Publication number: 20200261728
    Abstract: In various method embodiments for operating an implantable neural stimulator to deliver a neural stimulation therapy to an autonomic neural target, the method comprises using the implantable neural stimulator to deliver the neural stimulation therapy to the autonomic neural target, and evaluating an evoked response to the neural stimulation bursts. The neural stimulation therapy includes a plurality of neural stimulation bursts where each neural stimulation burst includes a plurality of neural stimulation pulses and successive neural stimulation bursts are separated by a time without neural stimulation pulses. Evaluating the evoked response includes sensing the evoked response to the neural stimulation bursts where sensing the evoked response includes sensing at least one physiological parameter affected by the neural stimulation bursts, comparing the sensed evoked response against a baseline, and determining if the evoked response substantially returns to the baseline between neural stimulation bursts.
    Type: Application
    Filed: May 6, 2020
    Publication date: August 20, 2020
    Inventors: Andrew P. Kramer, Jason J. Hamann
  • Patent number: 10702698
    Abstract: According to various method embodiments, a person is indicated for a therapy to treat a cardiovascular disease, and the therapy is delivered to the person to treat the cardiovascular disease. Delivering the therapy includes delivering a vagal stimulation therapy (VST) to a vagus nerve of the person at a therapeutically-effective intensity for the cardiovascular disease that is below an upper boundary at which upper boundary the VST would lower an intrinsic heart rate during the VST.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: July 7, 2020
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Weiying Zhao, Quan Ni, Stephen B. Ruble, Jason J. Hamann
  • Patent number: 10668287
    Abstract: In various method embodiments for operating an implantable neural stimulator to deliver a neural stimulation therapy to an autonomic neural target, the method comprises using the implantable neural stimulator to deliver the neural stimulation therapy to the autonomic neural target, and evaluating an evoked response to the neural stimulation bursts. The neural stimulation therapy includes a plurality of neural stimulation bursts where each neural stimulation burst includes a plurality of neural stimulation pulses and successive neural stimulation bursts are separated by a time without neural stimulation pulses. Evaluating the evoked response includes sensing the evoked response to the neural stimulation bursts where sensing the evoked response includes sensing at least one physiological parameter affected by the neural stimulation bursts, comparing the sensed evoked response against a baseline, and determining if the evoked response substantially returns to the baseline between neural stimulation bursts.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: June 2, 2020
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Andrew P. Kramer, Jason J. Hamann
  • Publication number: 20200086113
    Abstract: A neural stimulation system delivers neural stimulation to a target nerve with control of direction of propagation of evoked neural signals in one or more fiber types of the target nerve using electrode configuration, thereby providing effective therapy while minimizing unintended effects. In various embodiments, mechanical parameters of a multi-polar electrode are determined to provide directed propagation of the neural stimulation by effecting neural conduction block in or near the stimulation site. In various embodiments, the electrode includes a cathode for evoking action potentials and a plurality of anodes for blocking the propagation of the evoked action potentials in specified direction(s) and fiber type(s) while minimizing the formation of virtual cathodes.
    Type: Application
    Filed: October 2, 2019
    Publication date: March 19, 2020
    Inventors: Manfred Franke, David J. Ternes, Juan Gabriel Hincapie Ordonez, Stephen B. Ruble, Jason J. Hamann, Kevin J. Mohsenian, Jack Gordon
  • Patent number: 10575900
    Abstract: A catheter system includes a catheter comprising a tip assembly, the tip assembly having a plurality of electrodes and the plurality of electrodes are configured to measure electrical signals. The system also includes a processing unit configured to: receive a first electrical signal sensed by a first electrode of the plurality of electrodes and a second electrical signal sensed by a second electrode of the plurality of electrodes. A first vector is determined based on the first electrical signal that corresponds to the first electrode. A second vector is determined based on the second electrical signal that corresponds to the second electrode. A resultant vector is determined by summing at least the first vector and the second vector, wherein the resultant vector is indicative of the orientation of the tip assembly.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: March 3, 2020
    Assignee: Boston Scientific Scimed Inc
    Inventors: Jacob I. Laughner, Jason J. Hamann, Shibaji Shome, Allan C. Shuros, Mary M. Byron, Paul Hultz, Pramodsingh H. Thakur
  • Publication number: 20190351238
    Abstract: An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.
    Type: Application
    Filed: July 30, 2019
    Publication date: November 21, 2019
    Inventors: David J. Ternes, Jason J. Hamann, Stephen B. Ruble, Juan Gabriel Hincapie Ordonez, Manfred Franke
  • Patent number: 10434303
    Abstract: A neural stimulation system delivers neural stimulation to a target nerve with control of direction of propagation of evoked neural signals in one or more fiber types of the target nerve using electrode configuration, thereby providing effective therapy while minimizing unintended effects. In various embodiments, mechanical parameters of a multi-polar electrode are determined to provide directed propagation of the neural stimulation by effecting neural conduction block in or near the stimulation site. In various embodiments, the electrode includes a cathode for evoking action potentials and a plurality of anodes for blocking the propagation of the evoked action potentials in specified direction(s) and fiber type(s) while minimizing the formation of virtual cathodes.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: October 8, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Manfred Franke, David J. Ternes, Juan Gabriel Hincapie Ordonez, Stephen B. Ruble, Jason J. Hamann, Kevin J. Mohsenian, Jack Gordon
  • Patent number: 10413731
    Abstract: An example of a system may include a stimulator and at least one controller. The stimulator may be configured to deliver nerve stimulation to capture a first set of axons in a nerve and to deliver depletion block stimulation to capture a second set of axons in the nerve, where the second set is a subset of the first. The depletion block stimulation may include a series of pulses at a depletion pulse frequency within a range between about 100 Hz to about 1 kHz, and the nerve stimulation may include a series of pulses at a stimulation pulse frequency within a range of about 0.25 Hz to about 50 Hz. At least a portion of the nerve stimulation and at least a portion of the depletion block stimulation may be delivered to be effective in providing a nerve block while delivering nerve stimulation.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: September 17, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Manfred Franke, David J. Ternes, Juan Gabriel Hincapie Ordonez, Stephen B. Ruble, Jason J. Hamann
  • Patent number: 10391323
    Abstract: An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: August 27, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David J. Ternes, Jason J. Hamann, Stephen B. Ruble, Juan Gabriel Hincapie Ordonez, Manfred Franke
  • Patent number: 10376700
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: August 13, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble
  • Patent number: 10328264
    Abstract: A neurostimulation system delivers neurostimulation to a patient using one or more primary parameters and one or more secondary parameters. The one or more primary parameters are controlled for maintaining efficacy of the neurostimulation. The one or more secondary parameters are adjusted for preventing the patient from developing neural accommodation. In various embodiments, values for the one or more secondary parameters are varied during the delivery of the neurostimulation for prevention of neural accommodation that may result from a constant or periodic pattern of stimulation pulses.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: June 25, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jason J. Hamann, David J. Ternes, Stephen B. Ruble, Juan Gabriel Hincapie Ordonez
  • Publication number: 20190070418
    Abstract: A neurostimulation system provides for capture verification and stimulation intensity adjustment to ensure effectiveness of vagus nerve stimulation in modulating one or more target functions in a patient. In various embodiments, stimulation is applied to the vagus nerve, and evoked responses are detected to verify that the stimulation captures the vagus nerve and to adjust one or more stimulation parameters that control the stimulation intensity.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Inventors: Juan Gabriel Hincapie Ordonez, David J. Ternes, Jason J. Hamann, Stephen B. Ruble